TrialPath
Recruiting

PROV-MESH: Prophylactic Ovarian Cancer MESH

NCT07676370 · Hospital Vall d'Hebron
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Multicenter Randomized Clinical Trial Comparing Prophylactic Mesh Placement Versus Primary Closure, With or Without Negative Pressure Wound Therapy, in Patients Undergoing Primary or Interval Cytoreductive Surgery for Ovarian Cancer
About this study
Incisional hernia is a common complication after midline laparotomy and may significantly impact quality of life, morbidity, and healthcare costs. Patients undergoing cytoreductive surgery for ovarian cancer are considered at increased risk due to extensive surgical procedures, nutritional status, and exposure to systemic treatments. This prospective randomized clinical trial aims to evaluate whether prophylactic mesh placement during abdominal wall closure reduces the incidence of incisional hernia compared with conventional fascial closure in women undergoing cytoreductive surgery for ovarian cancer through a midline laparotomy. To control for the potential effect of negative pressure wound therapy (NPWT) on surgical site infection, participants will also be randomized to receive NPWT or standard wound dressing, resulting in four treatment arms.
Eligibility criteria
Inclusion Criteria: * Female patients diagnosed with ovarian carcinoma. * Undergoing primary cytoreductive surgery, interval cytoreductive surgery, or delayed cytoreductive surgery after six cycles of chemotherapy. * Surgical procedure performed through a midline laparotomy. * Ability and willingness to provide written informed consent. Exclusion Criteria: * Surgery for recurrent ovarian cancer (secondary, tertiary, or subsequent cytoreductions). * Minimally invasive surgical approach. * Planned secondary cytoreductive surgery during the 24-month follow-up period. * Inability or unwillingness to comply with follow-up requirements.
Study design
Enrollment target: 152 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-01-01
Estimated completion: 2030-12-31
Last updated: 2026-06-30
Interventions
Procedure: Prophylactic Mesh PlacementDevice: Negative Pressure Wound Therapy (NPWT)Procedure: Standard Fascial Closure
Primary outcomes
  • • Incidence of Incisional Hernia (24 months after surgery)
Sponsor
Hospital Vall d'Hebron · other
With: Germans Trias i Pujol Hospital, Fundación Jimenez Diaz de Madrid, Hospital Universitario La Fe
Contacts & investigators
ContactJose Luis Sánchez Iglesias, MD PhD · contact · jlsanig@yahoo.es · +34 932746000
All locations (1)
Hospital Universitario Vall d'HebronRecruiting
Barcelona, Barcelona, Spain